Regulatory Approval

Canada's first compliant stablecoin, QCAD, partners with VersaBank, leveraging bank-grade security to bridge the gap between crypto and traditional finance.

A new partnership between tech firm OnBoard and Stanford experts aims to redefine corporate governance with AI, promising greater insight and accountability.

UK insurers face a tight deadline for tough new PRA collateral rules. A new solution from Transcend aims to ease the burden and enhance risk oversight.

Asurity and MISMO are spearheading a data revolution to standardize mortgage compliance, promising huge efficiency gains and a new era of regulatory clarity.

A major multi-vendor study confirms AI's power for precision HER2 scoring, promising to improve diagnostics and accelerate personalized cancer therapies.

Regulators deem PRRS-resistant pigs safe, promising a future with less animal disease and antibiotic use, but sparking debate on consumer transparency.

Quanterix has submitted a multi-biomarker blood test to the FDA, a move that could revolutionize early Alzheimer's diagnosis and patient care.

A bipartisan bill in Congress aims to give veterans access to emerging mental health treatments, including the novel, non-hallucinogenic compound MEAI.

With a key drug for a rare disease nearing the finish line, Spruce adds two industry veterans to navigate the high-stakes FDA approval process.

New Medicare rules expand access to opioid alternatives, reshaping post-surgery recovery and rewarding companies at the forefront of pain management.

A breakthrough in cancer therapy as Avacta's faridoxorubicin proves so safe, regulators have removed historic dosing limits tied to heart toxicity.

Relay Therapeutics' experimental drug, zovegalisib, offers new hope for a common and hard-to-treat form of advanced breast cancer with a promising safety profile.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

Promega's new diagnostic for KEYTRUDA gains NMPA approval, opening doors for targeted solid tumor therapy amid China's growing precision medicine market.

McCain Foods launches its third 'Farm of the Future' in the UK, showcasing major strides in regenerative agriculture and setting ambitious 2030 climate goals.

A landmark Medicare decision doubles payment for contrast-enhanced ultrasound, positioning the safer, cheaper alternative to challenge CT and MRI dominance.

With a $201M war chest, Muzero Acquisition Corp joins a revitalized SPAC market, targeting the next big tech-enabled company in a high-stakes search.

TeraWulf is acquiring old industrial sites in KY and MD, adding massive power capacity for the AI boom while aiming to stabilize regional energy grids.

After a brutal cold snap, Michiganders face huge energy bills. Consumers Energy is offering aid, but it highlights a growing crisis of affordability.

A $6.8M judgment against a VA claims company reveals a battle for ethics, spurring laws to protect veterans from deceptive and costly practices.